Teleflex Signs Agreement with HealthTrust for Ligating Solutions
January 11 2016 - 6:15AM
Business Wire
Teleflex Incorporated (NYSE: TFX), a leading global
provider of medical devices for critical care and surgery,
announces a new group purchasing agreement with HealthTrust. The
agreement, which became effective Dec. 1, 2015, covers Teleflex’s
full line of manual ligation products, including the Weck®
Hem-o-Lok® polymer locking system, Horizon™ Titanium Clip System,
Hemoclip® Metal Clips and associated appliers.
Weck ligation products from Teleflex are designed to suit
clinicians’ preferences and procedural needs.
“Since the introduction of the Weck Metal Ligating Hemoclip in
1963, Teleflex has continued to work towards refining the science
of closure to produce metal and polymer ligation solutions for use
by surgeons around the world,” said John Tushar, president and
general manager of Teleflex Surgical. “We are pleased to have the
opportunity to bring these solutions to HealthTrust members.”
About HealthTrust
HealthTrust (legally known as Healthtrust Purchasing Group,
L.P.) is committed to strengthening provider performance and
clinical excellence through an aligned membership model and the
delivery of total cost management solutions, including supply chain
solutions and a contract and service portfolio unparalleled in
quality, scope and value. HealthTrust (www.healthtrustpg.com)
serves more than 1,400 acute care facilities and members in more
than 22,300 other locations, including ambulatory surgery centers,
physician practices, long-term care and alternate care sites.
Headquartered in Brentwood, Tennessee, HealthTrust is an
affiliate of Parallon Business Solutions,
LLC (www.parallon.com), a leading provider of healthcare
business and operational services, including revenue cycle
management, workforce and technology solutions. On Twitter
@healthtrustpg and @parallonconnect.
About Teleflex Incorporated
Teleflex is a global provider of medical technologies designed
to improve the health and quality of people’s lives. We apply
purpose driven innovation – a relentless pursuit of identifying
unmet clinical needs – to benefit patients and healthcare
providers. Our portfolio is diverse, with solutions in the fields
of vascular and interventional access, surgical, anesthesia,
cardiac care, urology, emergency medicine and respiratory care.
Teleflex employees worldwide are united in the understanding that
what we do every day makes a difference. For more information,
please visit teleflex.com.
Teleflex is the home of Arrow®, Deknatel®, Hudson RCI®, LMA®,
Pilling®, Rusch® and Weck® – trusted brands united by a common
sense of purpose.
Forward-Looking Statements
Any statements contained in this press release that do not
describe historical facts may constitute forward-looking
statements. Any forward-looking statements contained herein are
based on our management's current beliefs and expectations, but are
subject to a number of risks, uncertainties and changes in
circumstances, which may cause actual results or company actions to
differ materially from what is expressed or implied by these
statements. These risks and uncertainties are identified and
described in more detail in our filings with the Securities and
Exchange Commission, including our Annual Report on Form 10-K.
Teleflex, the Teleflex logo, Arrow, Deknatel, Hudson RCI, LMA,
Pilling, Rusch, Weck, Hem-o-lok, Hemoclip, and Horizon are
trademarks or registered trademarks of Teleflex Incorporated or its
affiliates, in the U.S. and/or other countries.© 2016 Teleflex
Incorporated. All rights reserved. MC-001916
View source
version on businesswire.com: http://www.businesswire.com/news/home/20160111005053/en/
Teleflex IncorporatedJake ElguiczeTreasurer and Vice President,
Investor Relations610-948-2836
Teleflex (NYSE:TFX)
Historical Stock Chart
From Mar 2024 to Apr 2024
Teleflex (NYSE:TFX)
Historical Stock Chart
From Apr 2023 to Apr 2024